Wei-hua H. Yan

Linhai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

Human leukocyte antigen-G in solid tumors: from immunotolerance to immunotherapy.

Human leukocyte antigen-G in solid tumors: from immunotolerance to immunotherapy.

Journal: Frontiers in immunology
Published: September 01, 2025

Human leukocyte antigen-G isoform HLA-G2/6, but not HLA-G1/4/5, is an independent indicator of poor survival in patients with colorectal cancer.

Human leukocyte antigen-G isoform HLA-G2/6, but not HLA-G1/4/5, is an independent indicator of poor survival in patients with colorectal cancer.

Journal: Frontiers in immunology
Published: July 24, 2025

HLA-G expression in peritumoral fundic gland mucous neck cells, but not in tumor lesions, related to poor survival in patients with gastric cancer.

HLA-G expression in peritumoral fundic gland mucous neck cells, but not in tumor lesions, related to poor survival in patients with gastric cancer.

Journal: Frontiers in immunology
Published: July 05, 2025

Prognostic risk stratification value of MACC1 expression in patients with gastric cancer.

Prognostic risk stratification value of MACC1 expression in patients with gastric cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: April 17, 2024

Pre-operative neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with gastric cancer.

Pre-operative neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with gastric cancer.

Journal: International immunopharmacology
Published: June 27, 2022

Editorial: The Biological and Clinical Aspects of HLA-G, Volume II.

Editorial: The Biological and Clinical Aspects of HLA-G, Volume II.

Journal: Frontiers in immunology
Published: June 02, 2022

Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer.

Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer.

Journal: International immunopharmacology
Published: March 11, 2022

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection.

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection.

Journal: Frontiers in immunology
Published: October 03, 2021

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.

Journal: Frontiers in immunology
Published: April 21, 2021

Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.

Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.

Journal: Frontiers in immunology
Published: March 11, 2021

Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge.

Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge.

Journal: International immunopharmacology
Published: January 26, 2021

Editorial: The Biological and Clinical Aspects of HLA-G.

Editorial: The Biological and Clinical Aspects of HLA-G.

Journal: Frontiers in immunology
Published: January 04, 2021
Showing 1-12 of 57

Last Updated: 09/26/2026